Drug Metabolism and Disposition

SJR Rank #4,492H-index: 202SJR: 1.054Best quartile: Q1APC: US$3,500
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Pharmaceutical ScienceQ1
  • PharmacologyQ1

Areas: Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsPharmacological Effects and Toxicity StudiesDrug-Induced Hepatotoxicity and ProtectionEicosanoids and Hypertension PharmacologyMetabolism and Genetic DisordersDiverse Scientific and Economic StudiesAnalytical Chemistry and ChromatographyInflammatory mediators and NSAID effectsHuman auditory perception and evaluation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025050100150200

Detailed Information

ISSN

0090-9556, 1521-009X

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

3.38

References per Document

54.33

Coverage

1973-2026

Scope

An important reference for all pharmacology and toxicology departments, Drug Metabolism and Disposition (DMD) is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolizing enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.

Metrics from SCImago Journal Rank 2025. View on SCImago